Evidence map›Paper›PMID 34576805›Full record

ArticleMicroorganisms2021

Sensitivity of Rapid Antigen Testing and RT-PCR Performed on Nasopharyngeal Swabs versus Saliva Samples in COVID-19 Hospitalized Patients: Results of a Prospective Comparative Trial (RESTART).

Antonios Kritikos, Giorgia Caruana, René Brouillet, John-Paul Miroz, Samia Abed-Maillard, Geraldine Stieger, Onya Opota, Antony Croxatto, Peter Vollenweider, Pierre-Alexandre Bart and 2 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Pooled it
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Antonios KritikosInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-9993-1555
Giorgia CaruanaInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-2899-1489
René BrouilletInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
John-Paul MirozIntensive Care Unit, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Samia Abed-MaillardIntensive Care Unit, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Geraldine StiegerIntensive Care Unit, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Onya OpotaInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-5421-0607
Antony CroxattoInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Peter VollenweiderService of Internal Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Pierre-Alexandre BartService of Internal Medicine, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Jean-Daniel ChicheIntensive Care Unit, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Gilbert GreubInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0001-9529-3317
University of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Saliva sampling could serve as an alternative non-invasive sample for SARS-CoV-2 diagnosis while rapid antigen tests (RATs) might help to mitigate the shortage of reagents sporadically encountered with RT-PCR. Thus, in the RESTART study we compared antigen and RT-PCR testing methods on nasopharyngeal (NP) swabs and salivary samples. We conducted a prospective observational study among COVID-19 hospitalized patients between 10 December 2020 and 1 February 2021. Paired saliva and NP samples were investigated by RT-PCR (Cobas 6800, Roche-Switzerland, Basel, Switzerland) and by two rapid antigen tests: One Step Immunoassay Exdia

Indexed as

rapid antigen testingRT-PCRsalivaSARS-CoV-2 diagnosisviral transport medium

Identifiers

PMID34576805
PMCPMC8464722
OpenAlexW3198443120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.